Daniel J Cameron

Summary

Publications

  1. ncbi request reprint Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial
    D Cameron
    Northern Westchester Hospital, Mount Kisco, NY, USA
    Minerva Med 99:489-96. 2008
  2. doi request reprint Clinical trials validate the severity of persistent Lyme disease symptoms
    Daniel J Cameron
    First Medical Associates, Mt Kisco, New York 10549, USA
    Med Hypotheses 72:153-6. 2009
  3. doi request reprint Insufficient evidence to deny antibiotic treatment to chronic Lyme disease patients
    Daniel J Cameron
    First Medical Associates, Medicine, 175 Main Street, Mount Kisco, NY 10549, USA
    Med Hypotheses 72:688-91. 2009

Detail Information

Publications3

  1. ncbi request reprint Severity of Lyme disease with persistent symptoms. Insights from a double-blind placebo-controlled clinical trial
    D Cameron
    Northern Westchester Hospital, Mount Kisco, NY, USA
    Minerva Med 99:489-96. 2008
    ..A significant gain in the QOL for subjects randomized to amoxicillin in this RCT without serious adverse events is consistent with the goal of improving patient's QOL and consequently worthy of further study...
  2. doi request reprint Clinical trials validate the severity of persistent Lyme disease symptoms
    Daniel J Cameron
    First Medical Associates, Mt Kisco, New York 10549, USA
    Med Hypotheses 72:153-6. 2009
    ....
  3. doi request reprint Insufficient evidence to deny antibiotic treatment to chronic Lyme disease patients
    Daniel J Cameron
    First Medical Associates, Medicine, 175 Main Street, Mount Kisco, NY 10549, USA
    Med Hypotheses 72:688-91. 2009
    ..Nevertheless, many health insurers - relying exclusively upon only one CPG - have a policy of automatically denying antibiotics to CLD patients regardless of the specifics of each case or the recommendations of the patient's physician...